You have 9 free searches left this month | for more free features.

Hepatitis C

Showing 26 - 50 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Liver Cancer Trial in Houston (Bevacizumab, Atezolizumab, Sofosbuvir)

Not yet recruiting
  • Liver Cancer
  • Houston, Texas
    M D Anderson Cancer Center
Feb 9, 2023

Hepatitis C, HCV Trial (Telehealth in Parole/Probation Office)

Recruiting
  • Hepatitis C
  • HCV
  • Telehealth in Parole/Probation Office
  • Lexington, Kentucky
    University of Kentucky
Oct 11, 2022

Hepatitis C, Chronic, Pregnancy; Infection Trial in Pittsburgh (Sofosbuvir/Velpatasvir 400 MG-100 MG Oral Tablet)

Recruiting
  • Hepatitis C, Chronic
  • Pregnancy; Infection
  • Sofosbuvir/Velpatasvir 400 MG-100 MG Oral Tablet
  • Denver, Colorado
  • +4 more
Dec 3, 2022

End Stage Renal Disease Trial in United States (Epclusa)

Recruiting
  • End Stage Renal Disease
  • Birmingham, Alabama
  • +8 more
Feb 1, 2023

The National Australian HCV Point-of-Care Testing Program - HCV

Not yet recruiting
  • Hepatitis C
  • Diagnostic Test: Point-of-Care Testing
  • (no location specified)
Feb 1, 2023

Opioid Use, Opioid Use Disorder, Risk Reduction Trial in Durham, Greensboro (Suboxone, Truvada, Mavyret)

Active, not recruiting
  • Opioid Use
  • +4 more
  • Durham, North Carolina
  • +1 more
Jan 19, 2023

Elimination of Hepatitis C Virus Among Users of Substances

Not yet recruiting
  • Hepatitis C in Substance Users
  • Sofosbuvir 400 MG / Velpatasvir 100 MG [Epclusa]
  • (no location specified)
Aug 14, 2022

Hepatitis C in Prison: Study of Screening and Rapid Treatment

Not yet recruiting
  • Chronic HIV Infection
  • Xpert® HCV Viral test
  • FibroScan® test
  • Paris, France
    Internal Medicine Service, Cochin Hospital (Consultation and Amb
Dec 10, 2022

Hepatitis C, Smoking Cessation Trial in Greenville (Cognitive Behavioral Counseling)

Completed
  • Hepatitis C
  • Smoking Cessation
  • Cognitive Behavioral Counseling
  • Greenville, South Carolina
    Prisma Health Internal Medicine Clinic
Jul 18, 2022

Male Infertility, HCV Trial in Al Qalyubiyah, Banha (Sofosbuvir +daclatasvir+ simeprevir+Ribavirin)

Recruiting
  • Male Infertility
  • HCV
  • Sofosbuvir +daclatasvir+ simeprevir+Ribavirin
  • Al Qalyūbīyah, Benha, Egypt
  • +1 more
Nov 7, 2022

Protect Egyptian Population Against Severe Corona Virus

Completed
  • Corona Virus Infection
  • Hepatitis
    • Zagazig, Sharkia, Egypt
      Zagazig University Hospitals
    Sep 28, 2022

    Chronic Hepatitis c Genotype 1 Trial in Moscow, Saint Petersburg (Narlaprevir, Ritonavir, Sofosbuvir)

    Completed
    • Chronic Hepatitis c Genotype 1
    • Moscow, Russian Federation
    • +4 more
    Oct 27, 2022

    Hepatitis C, Opioid-Related Disorders, Injection Drug Use Trial in Hazard (Sofosbuvir/velpatasvir (Epclusa®))

    Recruiting
    • Hepatitis C
    • +2 more
    • Sofosbuvir/velpatasvir (Epclusa®)
    • Hazard, Kentucky
      ARH Medical Mall
    Sep 25, 2022

    Hepatitis C Viral Trial in Dundee

    Active, not recruiting
    • Hepatitis C Viral
      • Dundee, United Kingdom
        NHS Tayside
      Nov 14, 2022

      HIV, Hepatitis C, Substance Use Disorders Trial (CJC-TraC)

      Enrolling by invitation
      • HIV
      • +2 more
      • CJC-TraC
      • Fond Du Lac, Wisconsin
      • +1 more
      Dec 1, 2022

      Hepatitis B, Hepatitis C, AIDS Trial in Rouen (Blood collection using Dried Blood Spot)

      Not yet recruiting
      • Hepatitis B
      • +2 more
      • Blood collection using Dried Blood Spot
      • Rouen, France
        CSAPA la Boussole
      May 20, 2022

      Long Term Follow up of Chronic HCV Patients Receiving DAAS

      Recruiting
      • Chronic Hepatitis c
        • Sohag, Egypt
          Sohag University Hospital
        Jun 29, 2022

        Opioid Use Disorder, HIV, Hepatitis C Trial (NIATx Coaching)

        Not yet recruiting
        • Opioid Use Disorder
        • +2 more
        • NIATx Coaching
        • (no location specified)
        Dec 19, 2022

        Hepatitis C, Hepatitis C Virus Infection, Response to Therapy of Trial in San Diego (glecaprevir/pibrentasvir (GLE/PIB))

        Completed
        • Hepatitis C
        • Hepatitis C Virus Infection, Response to Therapy of
        • glecaprevir/pibrentasvir (GLE/PIB)
        • San Diego, California
          University of California San Diego
        May 23, 2022

        Treatment of Hepatitis c by Using Direct-acting Antiviral

        Not yet recruiting
        • Hepatitis C
        • Direct Acting Antivirals
        • (no location specified)
        May 9, 2022

        Chronic Hepatitis, Hepatitis C Infection Trial in Puerto Rico, United States (Electroporation-Mediated Plasmid DNA Vaccine

        Active, not recruiting
        • Chronic Hepatitis
        • Hepatitis C Infection
        • Electroporation-Mediated Plasmid DNA Vaccine Therapy
        • +4 more
        • Jacksonville, Florida
        • +4 more
        Sep 20, 2022

        Hepatitis C, Chronic, Opioid-use Disorder Trial in Pittsburgh (Sofosbuvir/Velpatasvir)

        Completed
        • Hepatitis C, Chronic
        • Opioid-use Disorder
        • Pittsburgh, Pennsylvania
          Magee Womens Hospital of UPMC
        Aug 19, 2022

        Evaluating the Chain of Addiction Care (CAC)

        Recruiting
        • Hepatitis C, Chronic
        • Substance Use Disorders
          • Nijmegen, Gelderland, Netherlands
            Radboudumc
          May 31, 2022

          Hepatitis C Trial in Blain, Bouguenais, Nantes (Evaluation of the prevalence of HCV, HBV and HIV viral infections)

          Recruiting
          • Hepatitis C
          • Evaluation of the prevalence of HCV, HBV and HIV viral infections
          • Blain, France
          • +2 more
          Jun 8, 2022

          Hepatitis C, Chronic, Opioid Dependence, on Agonist Therapy Trial in Bergen, Stavanger (Health care delivery)

          Active, not recruiting
          • Hepatitis C, Chronic
          • Opioid Dependence, on Agonist Therapy
          • Health care delivery
          • Bergen, Hordaland, Norway
          • +1 more
          Aug 5, 2022